Biology of angiogenesis in tumors of the gastrointestinal tract

Microscopy Research and Technique

Volumn 60, Issue 2, 2003, Pages 199-207

  Reinmuth, Niels ^a   Parikh, Alexander A ^a   Ahmad, Syed A ^a   Liu, Wenbiao ^a   Stoeltzing, Oliver ^a   Fan, Fan ^a   Takeda, Akihiko ^a   Akagi, Morihisa ^a   Ellis, Lee M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Colon cancer; Endothelial cells; Gastric cancer; Pancreatic cancer; VEGF

Indexed keywords

CELL ENGINEERING; DISEASES; ENDOTHELIAL CELLS;

ANGIOGENESIS; ANGIOGENIC FACTOR; ANGIOGENIC PROCESS; CANCER BIOLOGY; COLON CANCER; ENDOTHELIAL-CELLS; GASTRIC CANCERS; GASTROINTESTINAL TRACT; PANCREATIC CANCERS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

TUMORS;

ANGIOGENIN; ANGIOPOIETIN; BASIC FIBROBLAST GROWTH FACTOR; CYCLOOXYGENASE 2; INTEGRIN; INTERLEUKIN 10; INTERLEUKIN 8; PLATELET DERIVED GROWTH FACTOR; THROMBOSPONDIN; THROMBOSPONDIN 1; THROMBOSPONDIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE; VASCULOTROPIN;

ANGIOGENESIS; COLON CANCER; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GASTROINTESTINAL TUMOR; HUMAN; HUMAN TISSUE; METASTASIS; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; STOMACH CANCER;

EID: 12244294062     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.10258     Document Type: Review

References (102)

1. Adachi Y, Itoh F, Yamamoto H, Arimura Y, Kukkawa-Okabe Y, Miyazaki K, Carbone DP, Imai K. 2001. Expression of angiomodulin (tumor-derived adhesion factor/mac25) in invading tumor cells correlates with poor prognosis in human colorectal cancer. Int J Cancer 95:216-222.
2. Ahmad SA, Liu W, Jung YD, Fan F, Reinmuth N, Bucana CD, Ellis LM. 2001a. Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcinoma. A possible mechanism for the initiation of angiogenesis. Cancer 92:1138-1143.
3. Ahmad SA, Liu W, Jung YD, Fan F, Wilson M, Reinmuth N, Shaheen RM, Bucana CD, Ellis LM. 2001b. The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer. Cancer Res 61:1255-1259.
4. Akagi Y, Liu W, Zebrowski B, Xie K, Ellis LM. 1998. Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I. Cancer Res 58:4008-4014.
5. Amaya H, Tanigawa N, Lu C, Matsumura M, Shimomatsuya T, Horiuchi T, Muraoka R. 1997. Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer. Cancer Lett 119:227-235.
6. Araya M, Terashima M, Takagane A, Abe K, Nishizuka S, Yonezawa H, Irinoda T, Nakaya T, Saito K. 1997. Microvessel count predicts metastasis and prognosis in patients with gastric cancer. J Surg Oncol 65:232-236.
7. Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, Strieter RM, 1996. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 97:2792-2802.
8. Baenziger NL, Brodie GN, Majerus PW. 1972. Isolation and properties of a thrombin-sensitive protein of human platelets. J Biol Chem 247:2723-2731.
9. Barton CM, Hall PA, Hughes CM, Gullick WJ, Lemoine NR. 1991. Transforming growth factor alpha and epidermal growth in human pancreatic cancer. J Pathol 163:111-116.
10. Basilico C, Moscatelli D. 1992. The FGF family of growth factors and oncogenes. Adv Cancer Res 59:115-165.
11. Beckner ME. 1999. Factors promoting tumor angiogenesis. Cancer Invest 17:594-623.
12. Bergsten E, Uutela M, Li X, Pietras K, Ostman A, Heldin CH, Alitalo K, Eriksson U. 2001. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat Cell Biol 3:512-516.
13. Bilato C, Pauly RR, Melillo G, Monticone R, Gorelick-Feldman D, Gluzband YA, Sollott SJ, Ziman B, Lakatta EG, Crow MT. 1995. Intracellular signaling pathways required for rat vascular smooth muscle cell migration. Interactions between basic fibroblast growth factor and platelet-derived growth factor. J Clin Invest 96:1905-1915.
14. Bouck N. 1990. Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. Cancer Cells 2:179-185.
15. Bouvet M, Ellis LM, Nishizaki M, Fujiwara T, Liu W, Bucana CD, Fang B, Lee JJ, Roth JA. 1998. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res 58:2288-2292.
16. Brooks PC, Clark RA, Cheresh DA. 1994. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264:569-571.
17. Cao R, Brakenhielm E, Li X, Pietras K, Widenfalk J, Ostman A, Eriksson U, Cao Y. 2002. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors. FASEB J 16:1575-1583.
18. Cheung N, Wong MP, Yuen ST, Leung SY, Chung LP. 1998. Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon. Hum Pathol 29:910-914.
19. Crosby JR, Tappan KA, Seifert RA, Bowen-Pope DF. 1999. Chimera analysis reveals that fibroblasts and endothelial cells require platelet-derived growth factor receptorbeta expression for participation in reactive connective tissue formation in adults but not during development. Am J Pathol 154:1315-1321.
20. Ellis LM, Takahashi Y, Fenoglio CJ, Cleary KR, Bucana CD, Evans DB. 1998. Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. Eur J Cancer 34:337-340.
21. Ellis LM, Liu W, Fan F, Reinmuth N, Shaheen RM, Jung YD, Ahmad S. 2001. Role of angiogenesis inhibitors in cancer treatment. Oncology (Huntingt) 15:39-46.
22. Etoh T, Inoue H, Tanaka S, Barnard GF, Kitano S, Mori M. 2001. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res 61:2145-2153.
23. Fidler IJ, Ellis LM. 1994. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79:185-188.
24. Fidler IJ, Singh RK, Yoneda J, Kumar R, Xu L, Dong Z, Bielenberg DR, McCarty M, Ellis LM. 2000. Critical determinants of neoplastic angiogenesis. Cancer J Sci Am 6 (Suppl 3) S225-236.
25. Fidler IJ, Kerbel RS, Ellis LM. 2001. Biology of cancer: angiogenesis. In: Devita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practices of oncology, 6th ed. Philadelphia: Lippincott, Williams & Wilkins. p 137-147.
26. Folkman J. 1986. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. Cancer Res 46:467-473.
27. Folkman J. 1990. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6.
28. Folkman J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1:27-31.
29. Fujimoto K, Hosotani R, Wada M, Lee JU, Koshiba T, Miyamoto Y, Tsuji S, Nakajima S, Doi R, Imamura M. 1998. Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis. Eur J Cancer 34:1439-1447.
30. Fuks Z, Persaud RS, Alfieri A, McLoughlin M, Ehleiter D, Schwartz JL, Seddon AP, Cordon-Cardo C, Haimovitz-Friedman A. 1994. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res 54:2582-2590.
31. Goldfarb M. 1996. Functions of fibroblast growth factors in vertebrate development. Cytokine Growth Factor Rev 7:311-325.
32. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ. 1999. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994-1998.
33. Hsu S, Huang F, Friedman E. 1995. Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect. J Cell Physiol 165:239-245.
34. Hynes RO. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11-25.
35. Ikeda N, Adachi M, Taki T, Huang C, Hashida H, Takabayashi A, Sho M, Nakajima Y, Kanehiro H, Hisanaga M, Nakano H, Miyake M. 1999. Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 79:1553-1563.
36. Ishigami SI, Arii S, Furutani M, Niwano M, Harada T, Mizumoto M, Mori A, Onodera H, Imamura M. 1998. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer 78:1379-1384.
37. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin CH. 1989. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338:557-562.
38. Itakura J, Ishiwata T, Friess H, Fujii H, Matsumoto Y, Buchler MW, Korc M. 1997. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin Cancer Res 3:1309-1316.
39. Ivaska J, Heino J. 2000. Adhesion receptors and cell invasion: mechanisms of integrin-guided degradation of extracellular matrix. Cell Mol Life Sci 57:16-24.
40. Johnson DE, Lu J, Chen H, Werner S, Williams LT. 1991. The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol 11:4627-4634.
41. Kang SM, Maeda K, Onoda N, Chung YS, Nakata B, Nishiguchi Y, Sowa M. 1997. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis. Int J Cancer 74:502-507.
42. Karademir S, Sokmen S, Terzi C, Sagol O, Ozer E, Astarcioglu H, Coker A, Astarcioglu I. 2000. Tumor angiogenesis as a prognostic predictor in pancreatic cancer. J Hepatobil Pancreat Surg 7:489-495.
43. Kasahara T, Mukaida N, Yamashita K, Yagisawa H, Akahoshi T, Matsushima K. 1991. IL-1 and TNF-alpha induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line. Immunology 74:60-67.
44. Kimura H, Konishi K, Nukui T, Kaji M, Maeda K, Yabushita K, Tsuji M, Miwa A. 2001. Prognostic significance ofexpression of thymidine phosphorylase and vascular endothelial growth factor in human gastric carcinoma. J Surg Oncol 76:31-36.
45. Kinoshita Y, Kinoshita C, Heuer JG, Bothwell M. 1993. Basic fibroblast growth factor promotes adhesive interactions of neuroepithelial cells from chick neural tube with extracellular matrix proteins in culture. Development 119:943-956.
46. Kitadai Y, Haruma K, Sumii K, Yamamoto S, Ue T, Yokozaki H, Yasui W, Ohmoto Y, Kajiyama G, Fidler IJ, Tahara E. 1998. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol 152:93-100.
47. Kitadai Y, Takahashi Y, Haruma K, Naka K, Sumii K, Yokozaki H, Yasui W, Mukaida N, Ohmoto Y, Kajiyama G, Fidler IJ, Tahara E. 1999. Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J cancer 81:647-653.
48. Konno S, Takebayashi Y, Aiba M, Akiyama S, Ogawa K. 2001. Clinicopathological and prognostic significance of thymidine phosphorylase and proliferating cell nuclear antigen in gastric carcinoma. Cancer Lett 166:103-111.
49. Ku DD, Zaleski JK, Liu S, Brock TA. 1993. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 265:H586-592.
50. Kuehn R, Lelkes PI, Bloechle C, Niendorf A, Izbicki JR. 1999. Angiogenesis, angiogenic growth factors, and cell adhesion molecules are upregulated in chronic pancreatic diseases: angiogenesis in chronic pancreatitis and in pancreatic cancer. Pancreas 18:96-103.
51. LaRochelle WJ, Jeffers M, McDonald WF, Chillakuru RA, Giese NA, Lokker NA, Sullivan C, Boldog FL, Yang M, Vernet C, Burgess CE, Fernandes E, Deegler LL, Rittman B, Shimkets J, Shimkets RA, Rothberg JM, Lichenstein HS. 2001. PDGF-D, a new protease-activated growth factor. Nat Cell Biol 3:517-521.
52. Lee JC, Chow NH, Wang ST, Huang SM. 2000. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer 36:748-753.
53. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.
54. Li D, Bell J, Brown A, Berry CL. 1994. The observation of angiogenin and basic fibroblast growth factor gene expression in human colonic adenocarcinomas, gastric adenocarcinomas, and hepatocellular carcinomas. J Pathol 172:171-175.
55. Liu W, Davis DW, Ramirez K, McConkey DJ, Ellis LM. 2001. Endothelial cell apoptosis is inhibited by a soluble factor secreted by human colon cancer cells. Int J Cancer 92:26-30.
56. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Sowa M. 1996. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77:858-863.
57. Maehara Y, Kabashima A, Koga T, Tokunaga E, Takeuchi H, Kakeji Y, Sugimachi K. 2000. Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma. Surgery 128:408-416.
58. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60.
59. Matsushima K, Baldwin ET, Mukaida N. 1992. Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines. Chem Immunol 51:236-265.
60. Maxwell PH, Dachs GU, Gleadle JM, Nicholls LG, Harris AL, Stratford IJ, Hankinson O, Pugh CW, Ratcliffe PJ. 1997. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 94:8104-8109.
61. Mazure NM, Chen EY, Laderoute KR, Giaccia AJ. 1997. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-rastransformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 90:3322-3331.
62. Miyamoto S, Teramoto H, Gutkind JS, Yamada KM. 1996. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J Cell Biol 135:1633-1642.
63. Moghaddam A, Zhang HT, Fan TP, Hu DE, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL, Bicknell R. 1995. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 92:998-1002.
64. Monestiroli S, Mancuso P, Burlini A, Pruneri G, Dell'Agnola C, Gobbi A, Martinelli G, Bertolini F. 2001. Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma. Cancer Res 61:4341-4344.
65. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L. 1986. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 83:7297-7301.
66. Nicosia RF, Tuszynski GP. 1994. Matrix-bound thrombospondin promotes angiogenesis in vitro. J Cell Biol 124:183-193.
67. Nor JE, Christensen J, Mooney DJ, Polverini PJ. 1999. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 154:375-384.
68. Ostman A, Heldin CH. 2001. Involvement of platelet-derived growth factor in disease: development of specific antagonists. Adv Cancer Res 80:1-38.
69. Pal S, Claffey KP, Dvorak HF, Mukhopadhyay D. 1997. The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways. J Biol Chem 272:27509-27512.
70. Pekny M, Ostman A, Hermansson A, Nister M, Heldin CH, Westermark B. 1994. Differences in binding to the solid substratum and extracellular matrix may explain isoform-specific paracrine effects of platelet-derived growth factor. Growth Factors 10:77-87.
71. Pepper MS, Ferrara N, Orci L, Montesano R. 1991. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181:902-906.
72. Peters KG. 1998. Vascular endothelial growth factor and the angiopoietins: working together to build a better blood vessel. Circ Res 83:342-343.
73. Rak J, Mitsuhashi Y, Bayko L, Filmus J, Sasazuki T, Kerbel RS. 1995. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 55:4575-4580.
74. Reinmuth N, Liu W, Jung YD, Ahmad SA, Shaheen RM, Fan F, Bucana CD, McMahon G, Gallick GE, Ellis LM. 2001. Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J 15:1239-1241.
75. Roger T, Out T, Mukaida N, Matsushima K, Jansen H, Lutter R. 1998. Enhanced AP-1 and NF-kappaB activities and stability of interleukin 8 (IL-8) transcripts are implicated in IL-8 mRNA superinduction in lung epithelial H292 cells. Biochem J 330:429-435.
76. Ross R, Glomset J, Kariya B, Harker L. 1974. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 71:1207-1210.
77. Ruoslahti E, Pierschbacher MD. 1987. New perspectives in cell adhesion: RGD and integrins. Science 238:491-497.
78. Sachinidis A, Locher R, Hoppe J, Vetter W. 1990. The platelet-derived growth factor isomers, PDGF-AA, PDGF-AB and PDGF-BB, induce contraction of vascular smooth muscle cells by different intracellular mechanisms. FEBS Lett 275:95-98.
79. Sage EH, Bornstein P. 1991. Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin. J Biol Chem 266:14831-14834.
80. Schonherr E, Jarvelainen HT, Sandell LJ, Wight TN. 1991. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem 266:17640-17647.
81. Shimoyama S, Gansauge F, Gansauge S, Negri G, Oohara T, Beger HG. 1996. Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness, Cancer Res 56:2703-2706.
82. Shiraishi A, Ishiwata T, Shoji T, Asano G. 1995. Expression of PCNA, basic fibroblast growth factor, FGF-receptor and vascular endothelial growth factor in adenomas and carcinomas of human colon. Acta Histochem Cytochem 28:21-29.
83. Shomori K, Sakatani T, Goto A, Matsuura T, Kiyonari H, Ito H. 1999. Thymidine phosphorylase expression in human colorectal mucosa, adenoma and carcinoma: role of p53 expression. Pathol Int 49:491-499.
84. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yancopoulos GD. 1998. Increased vascularization in mice overexpressing angiopoietin-1. Science 282:468-471.
85. Tahara E. 2000. Molecular aspects of invasion and metastasis of stomach cancer. Verh Dtsch Ges Pathol 84:43-49.
86. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM. 1995. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55:3964-3968.
87. Takahashi Y, Bucana CD, Liu W, Yoneda J, Kitadai Y, Cleary KR, Ellis LM. 1996a. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. [see comments]. J Natl Cancer Inst 88:1146-1151.
88. Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD, Ellis LM. 1996b. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res 2:1679-1684.
89. Takahashi Y, Tucker SL, Kitadai Y, Koura AN, Bucana CD, Cleary KR, Ellis LM. 1997. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg 132:541-546.
90. Takahashi Y, Bucana CD, Akagi Y, Liu W, Cleary KR, Mai M, Ellis LM. 1998. Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer. Clinic Cancer Res 4:429-434.
91. Taraboletti G, Roberts D, Liotta LA, Giavazzi R. 1990. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol 111:765-772.
92. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA. 1991. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266:11947-11954.
93. Tokunaga T, Nakamura M, Oshika Y, Abe Y, Ozeki Y, Fukushima Y, Hatanaka H, Sadahiro S, Kijima H, Tsuchida T, Yamazaki H, Tamaoki N, Ueyama Y. 1999. Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer. Br J Cancer 79:354-359.
94. Tsai JC, Goldman CK, Gillespie GY. 1995. Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg 82:864-873.
95. Tsuchida T, Kijima H, Tokunaga T, Oshika Y, Hatanaka H, Fukushima Y, Abe Y, Kawai K, Yoshida Y, Miura S, Yamazaki H, Tamaoki N, Ueyama Y, Nakamura M. 1999. Expression of the thrombospondin 1 receptor CD36 is correlated with decreased stromal vascularisation in colon cancer. Int J Oncol 14:47-51.
96. Tsuzuki Y, Carreira CM, Bockhorn M, Xu L, Jain RK, Fukumura D. 2001. Pancreas microenvironment promotes vegf expression and tumor growth: novel window models for pancreatic tumor angiogenesis and microcirculation. Lab Invest 81:1439-1451.
97. Uefuji K, Ichikura T, Mochizuki H. 2000. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Clin Cancer Res 6:135-138.
98. Weidner N, Semple JP, Welch WR, Folkman J. 1991. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1-8.
99. Wong MP, Cheung N, Yuen ST, Leung SY, Chung LP. 1999. Vascular endothelial growth factor is up-regulated in the early pre-malignant stage of colorectal tumour progression. Int J Cancer 81:845-850.
100. Xie K. 2001. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 12:375-391.
101. Yamanaka Y, Friess H, Buchler M, Beger HG, Uchida E, Onda M, Kobrin MS, Korc M. 1993. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 53:5289-5296.
102. Zabrenetzky V, Harris CC, Steeg PS, Roberts DD. 1994. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int J Cancer 59:191-195.